Drugmaker Endo Says Bankruptcy Likely Imminent -- WSJ

Dow Jones
2022/08/09

By Alexander Gladstone

 

Endo International PLC, the pharmaceutical manufacturer facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said Tuesday that it is likely to file for bankruptcy imminently.

The company said that it is in negotiations with a group of senior lenders that it expects will result in an agreement for a chapter 11 filing. Endo also said that it is in discussions with opioid litigants as well as other creditors but didn't say that it has reached a proposed deal with them.

The Wall Street Journal reported last month that Endo was moving toward filing for bankruptcy without an agreement in place with the various states, municipalities, and private plaintiffs suing the company for its role in producing and distributing opioids. Endo has denied liability in connection with the opioid crisis.

Write to Alexander Gladstone at alexander.gladstone@wsj.com

 

$(END)$ Dow Jones Newswires

August 09, 2022 09:32 ET (13:32 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10